Global Digital PCR (dPCR) and qPCR Market Report (2025–2036)
Market Overview
The global digital PCR (dPCR) and quantitative PCR (qPCR) market was valued at USD xxxx million in 2025 and is projected to reach USD xxxx million by 2036, growing at a CAGR of xx%. Increasing demand for precision diagnostics, rising prevalence of infectious diseases and cancer, and advancements in molecular biology research are driving market growth. dPCR offers superior sensitivity and accuracy, while qPCR remains the gold standard for quantification in clinical and research applications.
Impact of COVID-19
The pandemic significantly boosted demand for PCR technologies in 2020 due to widespread testing for SARS-CoV-2. Post-pandemic, PCR technologies continue to play a critical role in infectious disease surveillance, oncology diagnostics, and personalized medicine.
Segmentation Analysis
By Type
· Digital PCR (dPCR)
· Quantitative PCR (qPCR)
· Real-Time PCR Systems
· Consumables & Reagents
· Software & Services
By Application
· Clinical Diagnostics (infectious diseases, oncology, genetic disorders)
· Research Use (genomics, transcriptomics, biomarker discovery)
· Forensic Applications
· Agricultural & Environmental Testing
· Others
By End User
· Hospitals & Diagnostic Laboratories
· Research Institutes
· Pharmaceutical & Biotechnology Companies
· Academic Institutions
Regional Analysis
· North America: Leading market due to advanced healthcare infrastructure, strong R&D investments, and presence of major players.
· Europe: Growth supported by government-funded research programs and adoption of advanced molecular diagnostics.
· Asia-Pacific: Fastest-growing region, driven by expanding biotech hubs in China, India, and Japan, and increasing demand for infectious disease testing.
· South America: Moderate growth, with Brazil leading in molecular diagnostics adoption.
· Middle East & Africa: Emerging opportunities with increasing healthcare modernization and demand for affordable PCR technologies.
Key Players
· Thermo Fisher Scientific Inc.
· Roche Diagnostics
· QIAGEN N.V.
· Bio-Rad Laboratories Inc.
· Agilent Technologies Inc.
· Bioer Technology Co. Ltd.
· Biosynex SA
· Esco Micro Pte Ltd.
· Analytik Jena AG
· Techne (Bibby Scientific)
· Fluidigm Corporation
· RainDance Technologies Inc.
· Takara Bio Inc.
· Illumina Inc.
· Promega Corporation
Porter’s Five Forces
· Threat of New Entrants: Moderate, due to high R&D costs but growing demand.
· Bargaining Power of Suppliers: Moderate, with reliance on specialized reagents and instruments.
· Bargaining Power of Buyers: High, as hospitals and labs demand cost-effective yet advanced solutions.
· Threat of Substitutes: Moderate, with alternatives like next-generation sequencing (NGS).
· Industry Rivalry: High, with global players competing on innovation, accuracy, and pricing.
SWOT Analysis
Strengths: High accuracy and sensitivity, wide adoption across clinical and research applications. Weaknesses: High equipment and reagent costs, complex workflows. Opportunities: Growth in personalized medicine, expansion in emerging markets. Threats: Competition from NGS and other molecular technologies, regulatory hurdles.
Trend Analysis
· Rising demand for point-of-care PCR testing.
· Increasing adoption of digital PCR for rare mutation detection.
· Growth in automation and high-throughput PCR systems.
· Expansion of cloud-based data analysis platforms.
Drivers & Challenges
Drivers:
· Rising prevalence of infectious diseases and cancer.
· Increasing demand for precision diagnostics.
· Advancements in PCR technology and automation.
Challenges:
· High costs limiting accessibility in developing regions.
· Stringent regulatory approval processes.
· Competition from alternative molecular diagnostic technologies.
Value Chain Analysis
· Raw Material Suppliers (enzymes, reagents, consumables) → Instrument Manufacturers → Distributors/Healthcare Providers → Hospitals/Research Labs/Patients
· Integration of cloud-based analytics and partnerships with biotech firms are reshaping the value chain, improving efficiency and accessibility.
Recommendations for Stakeholders
· Manufacturers: Invest in portable, point-of-care PCR systems and expand reagent portfolios.
· Healthcare Providers: Integrate PCR technologies into routine diagnostics and personalized medicine.
· Investors: Focus on Asia-Pacific for high growth potential.
· Policy Makers: Support funding for molecular diagnostics and streamline regulatory approvals.
1. Market Overview of Digital PCR (DPCR) and QPCR
1.1 Digital PCR (DPCR) and QPCR Market Overview
1.1.1 Digital PCR (DPCR) and QPCR Product Scope
1.1.2 Market Status and Outlook
1.2 Digital PCR (DPCR) and QPCR Market Size by Regions:
1.3 Digital PCR (DPCR) and QPCR Historic Market Size by Regions
1.4 Digital PCR (DPCR) and QPCR Forecasted Market Size by Regions
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Digital PCR (DPCR) and QPCR Sales Market by Type
2.1 Global Digital PCR (DPCR) and QPCR Historic Market Size by Type
2.2 Global Digital PCR (DPCR) and QPCR Forecasted Market Size by Type
2.3 dPCR
2.4 QPCR
3. Covid-19 Impact Digital PCR (DPCR) and QPCR Sales Market by Application
3.1 Global Digital PCR (DPCR) and QPCR Historic Market Size by Application
3.2 Global Digital PCR (DPCR) and QPCR Forecasted Market Size by Application
3.3 Clinical Use
3.4 Research Use
3.5 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Digital PCR (DPCR) and QPCR Production Capacity Market Share by Manufacturers
4.2 Global Digital PCR (DPCR) and QPCR Revenue Market Share by Manufacturers
4.3 Global Digital PCR (DPCR) and QPCR Average Price by Manufacturers
5. Company Profiles and Key Figures in Digital PCR (DPCR) and QPCR Business
5.1 Thermo Fisher
5.1.1 Thermo Fisher Company Profile
5.1.2 Thermo Fisher Digital PCR (DPCR) and QPCR Product Specification
5.1.3 Thermo Fisher Digital PCR (DPCR) and QPCR Production Capacity, Revenue, Price and Gross Margin
5.2 Roche
5.2.1 Roche Company Profile
5.2.2 Roche Digital PCR (DPCR) and QPCR Product Specification
5.2.3 Roche Digital PCR (DPCR) and QPCR Production Capacity, Revenue, Price and Gross Margin
5.3 QIAGEN
5.3.1 QIAGEN Company Profile
5.3.2 QIAGEN Digital PCR (DPCR) and QPCR Product Specification
5.3.3 QIAGEN Digital PCR (DPCR) and QPCR Production Capacity, Revenue, Price and Gross Margin
5.4 Bio-rad
5.4.1 Bio-rad Company Profile
5.4.2 Bio-rad Digital PCR (DPCR) and QPCR Product Specification
5.4.3 Bio-rad Digital PCR (DPCR) and QPCR Production Capacity, Revenue, Price and Gross Margin
5.5 Agilent
5.5.1 Agilent Company Profile
5.5.2 Agilent Digital PCR (DPCR) and QPCR Product Specification
5.5.3 Agilent Digital PCR (DPCR) and QPCR Production Capacity, Revenue, Price and Gross Margin
5.6 Bioer
5.6.1 Bioer Company Profile
5.6.2 Bioer Digital PCR (DPCR) and QPCR Product Specification
5.6.3 Bioer Digital PCR (DPCR) and QPCR Production Capacity, Revenue, Price and Gross Margin
5.7 Biosynex
5.7.1 Biosynex Company Profile
5.7.2 Biosynex Digital PCR (DPCR) and QPCR Product Specification
5.7.3 Biosynex Digital PCR (DPCR) and QPCR Production Capacity, Revenue, Price and Gross Margin
5.8 Esco
5.8.1 Esco Company Profile
5.8.2 Esco Digital PCR (DPCR) and QPCR Product Specification
5.8.3 Esco Digital PCR (DPCR) and QPCR Production Capacity, Revenue, Price and Gross Margin
5.9 Analytik Jena
5.9.1 Analytik Jena Company Profile
5.9.2 Analytik Jena Digital PCR (DPCR) and QPCR Product Specification
5.9.3 Analytik Jena Digital PCR (DPCR) and QPCR Production Capacity, Revenue, Price and Gross Margin
5.10 Techne
5.10.1 Techne Company Profile
5.10.2 Techne Digital PCR (DPCR) and QPCR Product Specification
5.10.3 Techne Digital PCR (DPCR) and QPCR Production Capacity, Revenue, Price and Gross Margin
5.11 Fluidigm
5.11.1 Fluidigm Company Profile
5.11.2 Fluidigm Digital PCR (DPCR) and QPCR Product Specification
5.11.3 Fluidigm Digital PCR (DPCR) and QPCR Production Capacity, Revenue, Price and Gross Margin
5.12 RainDance Technologies
5.12.1 RainDance Technologies Company Profile
5.12.2 RainDance Technologies Digital PCR (DPCR) and QPCR Product Specification
5.12.3 RainDance Technologies Digital PCR (DPCR) and QPCR Production Capacity, Revenue, Price and Gross Margin
6. North America
6.1 North America Digital PCR (DPCR) and QPCR Market Size
6.2 North America Digital PCR (DPCR) and QPCR Key Players in North America
6.3 North America Digital PCR (DPCR) and QPCR Market Size by Type
6.4 North America Digital PCR (DPCR) and QPCR Market Size by Application
7. East Asia
7.1 East Asia Digital PCR (DPCR) and QPCR Market Size
7.2 East Asia Digital PCR (DPCR) and QPCR Key Players in North America
7.3 East Asia Digital PCR (DPCR) and QPCR Market Size by Type
7.4 East Asia Digital PCR (DPCR) and QPCR Market Size by Application
8. Europe
8.1 Europe Digital PCR (DPCR) and QPCR Market Size
8.2 Europe Digital PCR (DPCR) and QPCR Key Players in North America
8.3 Europe Digital PCR (DPCR) and QPCR Market Size by Type
8.4 Europe Digital PCR (DPCR) and QPCR Market Size by Application
9. South Asia
9.1 South Asia Digital PCR (DPCR) and QPCR Market Size
9.2 South Asia Digital PCR (DPCR) and QPCR Key Players in North America
9.3 South Asia Digital PCR (DPCR) and QPCR Market Size by Type
9.4 South Asia Digital PCR (DPCR) and QPCR Market Size by Application
10. Southeast Asia
10.1 Southeast Asia Digital PCR (DPCR) and QPCR Market Size
10.2 Southeast Asia Digital PCR (DPCR) and QPCR Key Players in North America
10.3 Southeast Asia Digital PCR (DPCR) and QPCR Market Size by Type
10.4 Southeast Asia Digital PCR (DPCR) and QPCR Market Size by Application
11. Middle East
11.1 Middle East Digital PCR (DPCR) and QPCR Market Size
11.2 Middle East Digital PCR (DPCR) and QPCR Key Players in North America
11.3 Middle East Digital PCR (DPCR) and QPCR Market Size by Type
11.4 Middle East Digital PCR (DPCR) and QPCR Market Size by Application
12. Africa
12.1 Africa Digital PCR (DPCR) and QPCR Market Size
12.2 Africa Digital PCR (DPCR) and QPCR Key Players in North America
12.3 Africa Digital PCR (DPCR) and QPCR Market Size by Type
12.4 Africa Digital PCR (DPCR) and QPCR Market Size by Application
13. Oceania
13.1 Oceania Digital PCR (DPCR) and QPCR Market Size
13.2 Oceania Digital PCR (DPCR) and QPCR Key Players in North America
13.3 Oceania Digital PCR (DPCR) and QPCR Market Size by Type
13.4 Oceania Digital PCR (DPCR) and QPCR Market Size by Application
14. South America
14.1 South America Digital PCR (DPCR) and QPCR Market Size
14.2 South America Digital PCR (DPCR) and QPCR Key Players in North America
14.3 South America Digital PCR (DPCR) and QPCR Market Size by Type
14.4 South America Digital PCR (DPCR) and QPCR Market Size by Application
15. Rest of the World
15.1 Rest of the World Digital PCR (DPCR) and QPCR Market Size
15.2 Rest of the World Digital PCR (DPCR) and QPCR Key Players in North America
15.3 Rest of the World Digital PCR (DPCR) and QPCR Market Size by Type
15.4 Rest of the World Digital PCR (DPCR) and QPCR Market Size by Application
16 Digital PCR (DPCR) and QPCR Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Segmentation Analysis
By Type
· Digital PCR (dPCR)
· Quantitative PCR (qPCR)
· Real-Time PCR Systems
· Consumables & Reagents
· Software & Services
By Application
· Clinical Diagnostics (infectious diseases, oncology, genetic disorders)
· Research Use (genomics, transcriptomics, biomarker discovery)
· Forensic Applications
· Agricultural & Environmental Testing
· Others
By End User
· Hospitals & Diagnostic Laboratories
· Research Institutes
· Pharmaceutical & Biotechnology Companies
· Academic Institutions
Regional Analysis
· North America: Leading market due to advanced healthcare infrastructure, strong R&D investments, and presence of major players.
· Europe: Growth supported by government-funded research programs and adoption of advanced molecular diagnostics.
· Asia-Pacific: Fastest-growing region, driven by expanding biotech hubs in China, India, and Japan, and increasing demand for infectious disease testing.
· South America: Moderate growth, with Brazil leading in molecular diagnostics adoption.
· Middle East & Africa: Emerging opportunities with increasing healthcare modernization and demand for affordable PCR technologies.
Key Players
· Thermo Fisher Scientific Inc.
· Roche Diagnostics
· QIAGEN N.V.
· Bio-Rad Laboratories Inc.
· Agilent Technologies Inc.
· Bioer Technology Co. Ltd.
· Biosynex SA
· Esco Micro Pte Ltd.
· Analytik Jena AG
· Techne (Bibby Scientific)
· Fluidigm Corporation
· RainDance Technologies Inc.
· Takara Bio Inc.
· Illumina Inc.
· Promega Corporation
